Help Navigate Complex Treatments for Patients With HIV

August 2026

New Rx doravirine/islatravir (Idvynso) will raise questions about how to treat HIV.

Think of it as similar to other once-daily single tablet combo regimens, such as bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy) or dolutegravir/lamivudine (Dovato).

But new doravirine/islatravir is ONLY for patients who are already on a stable antiretroviral therapy (ART) regimen...haven’t failed previous ART...and aren’t resistant to doravirine.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Immunizations Vaccines in Pregnancy: What’s Recommended and When?
Acute Pain Help Manage Acute Pain in Patients With Opioid Use Disorder
Hypertension Baxdrostat Will Be a New Rx for Resistant Hypertension
Practice Mnemonics: The Memory Trick Every Pharmacy Tech Should Know
Rumor vs Truth Help Untangle Opioid-Related Rumors
Education and Training Beyond “Great Job”: Giving Feedback to Grow Learners
HIV & AIDS Help Navigate Complex Treatments for Patients With HIV
NatMed Spotlight Be Aware of Precautions With Sea Moss Supplements

Help Navigate Complex Treatments for Patients With HIV

Practical advice for a better career, with unlimited access to CE

Table of Contents